News
Expert Panel of India's Central Drug Authority, Which Recently Reviewed Serum Institute's ... - Latest Tweet by PTI News
The latest Tweet by PTI News states, 'Expert panel of India's Central Drug Authority, which recently reviewed Serum Institute's application seeking emergency authorisation of COVID-19 vaccine Covovax, has sought additional data from firm, while noting the jab has not yet been approved in country of origin: Sources'
Expert panel of India's Central Drug Authority, which recently reviewed Serum Institute's application seeking emergency authorisation of COVID-19 vaccine Covovax, has sought additional data from firm, while noting the jab has not yet been approved in country of origin: Sources— Press Trust of India (@PTI_News) November 28, 2021
(The above story first appeared on LatestLY on Nov 28, 2021 11:24 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
